Study to Assess Adverse Events When Ubrogepant Tablets in Combination With Atogepant Tablets Are Used to Treat Adult Participants With Migraine
Clinical trial NCT05264129 · COMPLETED
Trial details
- NCT number
- NCT05264129
- Sponsor
- AbbVie
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-07
- Primary completion
- 2023-04-04
- Enrollment
- 263
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.